REPORT ID 3023

United States ADHD Drugs Market Report 2017

Publish Date
12-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the United States ADHD Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of ADHD Drugs in these regions, from 2012 to 2022 (forecast).

United States ADHD Drugs market competition by top manufacturers/players, with ADHD Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Eli Lilly
    Janssen Pharmaceuticals, Inc.
    Shire
    Perdue Pharma
    Glaxosmith Kline
    Novartis
    Celltech Group
    Johnson & Johnson

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Stimulants (Amphetamines, Methylphenidate)
    Non-Stimulants
    Antidepressants
    Blood Pressure Medicines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Adults
    Children

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States ADHD Drugs Market Report 2017
1 ADHD Drugs Overview
    1.1 Product Overview and Scope of ADHD Drugs
    1.2 Classification of ADHD Drugs by Product Category
        1.2.1 United States ADHD Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States ADHD Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Stimulants (Amphetamines, Methylphenidate)
        1.2.4 Non-Stimulants
        1.2.5 Antidepressants
        1.2.6 Blood Pressure Medicines
    1.3 United States ADHD Drugs Market by Application/End Users
        1.3.1 United States ADHD Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Adults
        1.3.3 Children
    1.4 United States ADHD Drugs Market by Region
        1.4.1 United States ADHD Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West ADHD Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest ADHD Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic ADHD Drugs Status and Prospect (2012-2022)
        1.4.5 New England ADHD Drugs Status and Prospect (2012-2022)
        1.4.6 The South ADHD Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest ADHD Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of ADHD Drugs (2012-2022)
        1.5.1 United States ADHD Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States ADHD Drugs Revenue and Growth Rate (2012-2022)

2 United States ADHD Drugs Market Competition by Players/Suppliers
    2.1 United States ADHD Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States ADHD Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States ADHD Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States ADHD Drugs Market Competitive Situation and Trends
        2.4.1 United States ADHD Drugs Market Concentration Rate
        2.4.2 United States ADHD Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers ADHD Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States ADHD Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States ADHD Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States ADHD Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States ADHD Drugs Price by Region (2012-2017)

4 United States ADHD Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States ADHD Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States ADHD Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States ADHD Drugs Price by Type (2012-2017)
    4.4 United States ADHD Drugs Sales Growth Rate by Type (2012-2017)

5 United States ADHD Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States ADHD Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States ADHD Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States ADHD Drugs Players/Suppliers Profiles and Sales Data
    6.1 Eli Lilly
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 ADHD Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Janssen Pharmaceuticals, Inc.
        6.2.2 ADHD Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Shire
        6.3.2 ADHD Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Perdue Pharma
        6.4.2 ADHD Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Glaxosmith Kline
        6.5.2 ADHD Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis
        6.6.2 ADHD Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Celltech Group
        6.7.2 ADHD Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Johnson & Johnson
        6.8.2 ADHD Drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 ADHD Drugs Manufacturing Cost Analysis
    7.1 ADHD Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of ADHD Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 ADHD Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States ADHD Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States ADHD Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States ADHD Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States ADHD Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States ADHD Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer